Sentiment: Positive or negative news, rumors, or analyst ratings regarding IVBT or the broader biotech industry can significantly impact investor sentiment and drive stock price fluctuations.

Financial Performance: IVBT's revenue, profitability, cash flow, and debt levels are crucial indicators of its financial health. Strong financial results typically boost investor confidence, while weak performance can lead to selling pressure.

Clinical Trial Results: As a biotech company, positive results from clinical trials for IVBT's drug candidates can trigger substantial stock price increases. Conversely, negative or inconclusive results can lead to sharp declines.

Regulatory Approvals: FDA approval of IVBT's drugs is a major catalyst for stock price appreciation. Delays or rejections in the approval process can negatively affect the stock.

Competition: The competitive landscape in the biotech industry, including the emergence of new therapies or increased market share by rivals, can affect IVBT's growth prospects and stock price.

Market Conditions: Overall market sentiment, economic conditions, and industry trends influence investor risk appetite and valuations, impacting IVBT's stock price along with other biotech companies.

Partnerships and Acquisitions: Announcements of strategic partnerships, collaborations, or acquisitions involving IVBT can signal growth opportunities and positively impact the stock price.

Intellectual Property: The strength and scope of IVBT's patents and intellectual property portfolio are important factors in protecting its market position and attracting investors.

Management Team: The experience, expertise, and track record of IVBT's management team can influence investor confidence in the company's ability to execute its strategy and create value.

Investor Relations: Effective communication with investors through press releases, investor presentations, and conference calls can help manage expectations and maintain a favorable stock valuation.